Medicare Risk Adjusters: A New Frontier and Potential Legal Issues for Plans and Providers
June 16, 2009
Foley Senior Counsel Robert Slavkin is moderating a teleconference for the American Health Lawyers Association (AHLA) titled “Medicare Risk Adjusters: A New Frontier and Potential Legal Issues for Plans and Providers,” on June 16, 2009 from 1:00 p.m. – 2:30 p.m. Eastern.
This teleconference will:
- Provide an overview regarding Medicare risk adjusters and affected payments, including CY 2010 uniform (downward) adjustment;
- Review the CMS enforcement trends;
- Discuss the analysis of challenges that Plans and Providers may face, such as plans collecting and verifying data and adopting risk adjusters, and the possibility of providers as downstream entities being requested to assist in data collection; and
- Discuss the Plan and Provider issues and challenges in complying with obligations under MA Plan contracts.
Speakers include:
- Sean Creighton
Director, Division of Risk Adjustment Operations
Centers for Medicare and Medicaid Services, Baltimore, MD
- Anne W. Hance, Esquire
McDermott Will & Emery LLP, Washington, DC
- Janice H. Ziegler, Esquire
Sonnenschein Nath & Rosenthal LLP, Washington, DC
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.